By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere today reported that its fourth-quarter revenues more than doubled as it nudged ahead of analysts' consensus estimate.

The Northbrook, Ill.-based molecular diagnostics firm reported revenues of $828,000 for the quarter ended Dec. 31, compared to revenues of $310,000 for the fourth quarter of 2010. It beat analysts' expectations for $810,000 in revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.